Press Release
Trust.med and Kvinta Unite to Offer Lifeline for Pharmaceutical Suppliers Struggling with United States Compliance Challenges
Trust.med and Kvinta Unite to Offer Lifeline for Pharmaceutical Suppliers Struggling with United States Compliance Challenges
September 10, 2024
Cleveland, Ohio – Trust.med, a pioneering provider of data exchange solutions, and Kvinta, a global leader in serialization technology, are excited to unveil a unified initiative designed to support pharmaceutical suppliers struggling with underperforming technology providers. This collaborative effort offers a comprehensive, cost-effective solution that empowers suppliers and logistics providers to achieve seamless product serialization and data exchange. With accelerated onboarding, this initiative is designed to meet urgent timelines and deliver results.
Addressing Urgent Industry Challenges
The pharmaceutical supply chain is under increasing pressure to comply with the Drug Supply Chain Security Act (DSCSA) enhanced drug distribution security requirements, which take effect on November 27, 2024. Many suppliers are struggling to deliver accurate, complete, and timely serialized product tracing data to their downstream partners, posing risks of supply chain disruptions and compliance failures.
Recent communications from major distributors highlight the urgent need for suppliers to meet these critical requirements to maintain the integrity of the entire supply chain.
Kvinta and Trust.med’s collaboration directly addresses these challenges by empowering pharmaceutical trading partners to efficiently serialize their products and exchange EPCIS data across networks. This joint offering not only reduces the costs associated with serialization and data exchange but also delivers enhanced technical functionality and superior customer support.
“We are thrilled to join forces with Trust.med in this endeavor,” said Stepan Lialine, CEO at Kvinta. “Our combined expertise provides the pharmaceutical industry with a robust solution that not only meets regulatory requirements but also drives operational efficiency and cost savings.”
Learn More and Estimate Costs
To help pharmaceutical supply chain partners navigate DSCSA compliance, Kvinta and Trust.med have launched a dedicated landing page featuring a cost-estimation calculator and key benefits of their strategic alliance. Learn more, estimate costs, and book a meeting for a 1:1 consultation with the organizations:
Kvinta + Trust.med Seamless Serialization and Data Exchange
"We’re excited to collaborate with Kvinta in delivering a comprehensive solution that empowers pharmaceutical suppliers to navigate the complexities of DSCSA compliance,” said John Winkler, Chief Product Officer at Trust.med. “Our combined offering simplifies data exchange and serialization, providing the speed, accuracy, and cost-efficiency needed to stay compliant while enhancing operational performance."
About Kvinta
Kvinta is a modern, flexible SaaS solution that addresses the traceability and serialization needs of businesses across the pharmaceutical supply chain. Kvinta easily integrates into companies' IT landscapes and business processes, helping them meet DSCSA requirements and other global track and trace regulations while creating new business opportunities.
Website: https://kvinta.com/
About Trust.med
Trust.med offers state-of-the-art data exchange solutions designed specifically for the pharmaceutical sector. By enabling seamless, secure, and cost-effective data sharing between trading partners, Trust.med empowers companies to optimize their supply chain operations and meet compliance requirements with ease.
Website: https://trust.med